Target- |
MechanismGABA receptors modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismCHRNA7 positive allosteric modulator |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Anvyl LLC
0 Patents (Medical) associated with Anvyl LLC
100 Deals associated with Anvyl LLC
100 Translational Medicine associated with Anvyl LLC